Single-arm,Two Phase,Multicenter Trial to Evaluating the Efficacy and Safety of the CAR-T for Stomach Cancer

Trial Profile

Single-arm,Two Phase,Multicenter Trial to Evaluating the Efficacy and Safety of the CAR-T for Stomach Cancer

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 27 Mar 2017

At a glance

  • Drugs EPCAM-targeted CAR-T cells (Primary)
  • Indications Gastric cancer
  • Focus Therapeutic Use
  • Sponsors Sinobioway Cell Therapy
  • Most Recent Events

    • 21 Mar 2017 Status changed from suspended to recruiting.
    • 13 Mar 2017 Planned End Date changed from 1 May 2019 to 1 Nov 2019.
    • 13 Mar 2017 Planned primary completion date changed from 1 Oct 2016 to 1 Nov 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top